Category: Cancer Treatment
Global Cancer Treatment
-
Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029
... Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029 The cell culture market ... Read More
-
Therapeutics Enzymes Market Forecasts to 2028 – Global Analysis By Product Type (Chitinase, Asparginase and Other Product Types), By Application (Leukemia, Stomach Disorders and Other Applications), By End User (Drug manufacturers, Hospitals, Private clinics and Research laboratories) and Geography
... Research laboratories) and Geography According to Stratistics MRC, the Global Therapeutic Enzymes Market is accounted for $8467.9 million in 2022 and is expected to reach $18684.8 million by 2028 growing at a CAGR of 14.1% ... Read More
-
Minimal Residual Disease Testing Market by Technology (PCR, Flow Cytometry, NGS), Application (Leukemia, Lymphoma, Solid Tumors), End User(Hospitals, Specialty Clinics, Diagnostic Labs, Research and Academic Institutes) & Region - Global Forecast to 2027
... minimal residual disease testing market is valued at an estimated USD 1.2 Billion in 2022 and is projected to reach USD 2.3 Billion by 2027, at a CAGR of 14.0% during the forecast period. Market ... Read More
-
Heart Tumor Market Research Report - Forecast till 2030
... 783.34 million in 2021. A cardiac tumor is an abnormal development of the heart that can be either cancerous (malignant) or non-cancerous. Primary (arising from the heart itself) and secondary cardiac tumors are further classifications ... Read More
-
Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032
... small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage ... Read More
-
Chemotherapy At Home Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
... factors include growing incidences of different types of cancer, and rising preferences towards at-home medical care, are bolstering the growth of the market. Chemotherapy is a medical practice that is mainly conducted for cancer patients. ... Read More
-
The World Market for Liquid Biopsy, 2023
... Market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships. Liquid biopsy is gaining acceptance each year. ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market Insights, Forecast to 2028
... Therapeutics estimated at US$ 15,175.51 million in the year 2022, is projected to reach a revised size of US$ 28,717.44 million by 2028, growing at a CAGR of 11.22% during the forecast period 2022-2028. The ... Read More
-
Molecular Oncology Diagnostics Market - A Global and Regional Analysis: Focus on Product, Technology, Application, Cancer Type, End User, and Region - Analysis and Forecast, 2022-2032
... molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032. The growth in the global ... Read More
-
Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), and Region - Global Forecast to 202
... home healthcare market is projected to reach USD 340.2 Billion by 2027 from USD 226.0 Billion in 2022, at a CAGR of 8.5% during the forecast period Growth in this market is mainly driven by ... Read More
-
Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma (Non-Hodgkin, Hodgkin), Technology (PCR, NGS), End User - Global Forecast to 2027
... market is projected to reach USD 5.6 billion by 2027 from an estimated USD 2.9 Billion in 2022, at a CAGR of 14.2%. The growth in this market is attributed to the growing incidence of ... Read More
-
NAMPT Inhibitors Pipeline Analysis (Phase: Phase II, Phase I/II, Phase I, and Preclinical; and Type of Molecule: Small Molecules and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Analysis Market – Scope of Report TMR’s report on the global NAMPT inhibitors pipeline analysis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Bladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Diffuse Large B-cell Lymphoma Therapeutics Market - 2022-2029
... by 2028, growing at a CAGR of 7.50 % during the forecast period (2022-2029). Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). DLBCL is an aggressive (fast-growing) NHL that ... Read More
-
Liquid Biopsy Market by Product (Assay Kits, Instruments), Circulating Biomarkers (CTC, ctDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast), Non-Cancer), Sample Type (Blood), End User (Reference Lab, Hospitals) - Global Forecast to 2027
... liquid biopsy market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% during the forecast period. Market growth is driven by factors such as ... Read More
-
Cancer Diagnostics Oncology Companion Diagnostics Market Research Report 2022-2030
... growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Cancer Diagnostics Oncology Companion ... Read More
-
Doxorubicin Market Research Report 2022-2030
... opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Doxorubicin market size is growing ... Read More
-
Liposomal Doxorubicin Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Liposomal Doxorubicin market size is growing at a CAGR of 16.2% during ... Read More
-
Non-Invasive Cancer Diagnostics Market Forecasts to 2028 – Global Analysis By Therapeutics (Lung Cancer, Breast Cancer, Solid Tumors and Other Therapeutics), By Technology (Clinical Chemistry, Spectroscopy, Immunoassay and Other Technologies), By End User (Hospitals & Clinics, Ambulatory Care and Other End Users) and Geography
... Clinics, Ambulatory Care and Other End Users) and Geography According to Stratistics MRC, the Global Non-Invasive Cancer Diagnostics Market is accounted for $114.23 billion in 2022 and is expected to reach $191.57 billion by 2028 ... Read More
-
Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technology (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC, Colorectal, Prostate), and End user - Global Forecast to 2029
... market is projected to reach $8.52 billion by 2029, at a CAGR of 7.4% from 2022 to 2029. Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out ... Read More
-
2022 World Immunoassay Analyzers and Reagents in 98 Countries—Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests Performed in Hospitals, Commercial/Private Labs and POC Locations - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities in Suppliers
... Commercial/Private Labs and POC Locations - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities in Suppliers This new 98-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. The report provides ... Read More
-
Cancer/Tumor Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
... projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period. Growth in this market is majorly driven by rising funding investments in ... Read More
-
Global Plasmid DNA Manufacturing Market Size study & Forecast, by Grade (R&D Grade, GMP Grade), by Development (Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics), by Application (DNA Vaccines, Cell & Gene Therapy, Immunotherapy, Others), by Disease (Infectious Disease, Cancer, Genetic Disorder) and Regional Analysis, 2022-2029
... (Infectious Disease, Cancer, Genetic Disorder) and Regional Analysis, 2022-2029 Global Plasmid DNA Manufacturing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Medical Marijuana Market Size study & Forecast, by Formulation Type (Capsules, Oils, and Other Formulation Types) by Application (Chronic Pain, Arthritis, Migraine, Cancer, and Other Applications) and Regional Analysis, 2022-2029
... is valued approximately at USD 11.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 21.06% over the forecast period 2022-2029. Medical marijuana, also referred to as medical ... Read More
-
In Situ Hybridization Market by Products (Consumables, Instruments, Software), Technology (DNA FISH, RNA FISH, PNA FISH, CISH), Application (Cancer, Immunology, Neuroscience, Cytology), End User (Hospitals, Pharma, Biotech, CROs) – Global Forecast to 2027
... in situ hybridization market is projected to reach USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 12.6% during the forecast period. Companion diagnostic products showcase a significant potential ... Read More